Terms: = Gastric cancer AND CBFA2T3, ETO2, 863, ENSG00000129993, ZMYND4, MTGR2, MTG16 AND Prognosis
12 results:
1. Novel nomogram to predict the overall survival of postoperative patients with gastric signet.
Liu D; Ding R; Wang L; Shi E; Li X; Zhang C; Zhang Y; Wang X
BMC Gastroenterol; 2023 Aug; 23(1):284. PubMed ID: 37587418
[TBL] [Abstract] [Full Text] [Related]
2. [High expression of death-associated protein 5 promotes glucose metabolism in gastric cancer cells and correlates with poor survival outcomes].
Wang Q; Zhang Z; Wang L; Wang Y; Yao X; Wang Y; Zhang X; Ge S; Zuo L
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jul; 43(7):1063-1070. PubMed ID: 37488788
[TBL] [Abstract] [Full Text] [Related]
3. A novel adenosine signalling-based prognostic signature in gastric cancer and its association with cancer immune features and immunotherapy response.
Yu Y; Wang Y; Xi D; Wang N; Gao L; Shi Q; Yu R; Li H; Xiang L; Maswikiti EP; Chen H
Cell Biol Int; 2023 Sep; 47(9):1650-1664. PubMed ID: 37366248
[TBL] [Abstract] [Full Text] [Related]
4. HOTAIR as a diagnostic and prognostic biomarker of gastrointestinal cancers: an updated meta-analysis and bioinformatics analysis based on TCGA data.
Yang J; Xu S; Wang S; Zou X; Duan M; Zhang Q; Wang C
Biosci Rep; 2023 Mar; 43(3):. PubMed ID: 36924407
[TBL] [Abstract] [Full Text] [Related]
5. HOXC10 indicates poor survival outcome in gastric cancer and promotes G1/S cell cycle transition through transcriptional repression of p21.
Lin ZH; He JM; Lai SC; Ding N; Jiang Y; He XK; Liu XS; Huang ZH
Neoplasma; 2022 Dec; 69(6):1303-1313. PubMed ID: 36264773
[TBL] [Abstract] [Full Text] [Related]
6. The Value of lncRNA GHET1 as a Prognostic Factor for Survival of Chinese cancer Outcome: A Meta-Analysis.
Song J; Chen X; Tian Q; Lun L; Wang Q; Wang H; Li X; Liu Z; Tian L; Jing X; Zhang Y; Tian R
Dis Markers; 2019; 2019():5824190. PubMed ID: 31885739
[TBL] [Abstract] [Full Text] [Related]
7. Second cancers in MPN: Survival analysis from an international study.
Marchetti M; Ghirardi A; Masciulli A; Carobbio A; Palandri F; Vianelli N; Rossi E; Betti S; Di Veroli A; Iurlo A; Cattaneo D; Finazzi G; Bonifacio M; Scaffidi L; Patriarca A; Rumi E; Casetti IC; Stephenson C; Guglielmelli P; Elli EM; Palova M; Rapezzi D; Erez D; Gomez M; Wille K; Perez-Encinas M; Lunghi F; Angona A; Fox ML; Beggiato E; Benevolo G; Carli G; Cacciola R; McMullin MF; Tieghi A; Recasens V; Isfort S; Pane F; De Stefano V; Griesshammer M; Alvarez-Larran A; Vannucchi AM; Rambaldi A; Barbui T
Am J Hematol; 2020 Mar; 95(3):295-301. PubMed ID: 31816122
[TBL] [Abstract] [Full Text] [Related]
8. CIP2A overexpression is associated with c-Myc expression in colorectal cancer.
Böckelman C; Koskensalo S; Hagström J; Lundin M; Ristimäki A; Haglund C
Cancer Biol Ther; 2012 Mar; 13(5):289-95. PubMed ID: 22310977
[TBL] [Abstract] [Full Text] [Related]
9. The ratio of intra-tumoral regulatory T cells (Foxp3+)/helper T cells (CD4+) is a prognostic factor and associated with recurrence pattern in gastric cardia cancer.
Kim HI; Kim H; Cho HW; Kim SY; Song KJ; Hyung WJ; Park CG; Kim CB
J Surg Oncol; 2011 Dec; 104(7):728-33. PubMed ID: 21792941
[TBL] [Abstract] [Full Text] [Related]
10. Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer.
García I; Vizoso F; Martín A; Sanz L; Abdel-Lah O; Raigoso P; García-Muñiz JL
Ann Surg Oncol; 2003 Apr; 10(3):234-41. PubMed ID: 12679307
[TBL] [Abstract] [Full Text] [Related]
11. [Stomach cancer: 10 years experiences with surgical treatment and possibilities for improving the prognosis].
Spataro V; Genoni M; Maurer C; Müller W
Helv Chir Acta; 1993 Mar; 59(4):589-95. PubMed ID: 8473176
[TBL] [Abstract] [Full Text] [Related]
12. Proliferative activity and malignancy in human gastric cancers. Significance of the proliferation rate and its clinical application.
Ohyama S; Yonemura Y; Miyazaki I
Cancer; 1992 Jan; 69(2):314-21. PubMed ID: 1728362
[TBL] [Abstract] [Full Text] [Related]
